These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 38981438)
1. Multi-scale signaling and tumor evolution in high-grade gliomas. Liu J; Cao S; Imbach KJ; Gritsenko MA; Lih TM; Kyle JE; Yaron-Barir TM; Binder ZA; Li Y; Strunilin I; Wang YT; Tsai CF; Ma W; Chen L; Clark NM; Shinkle A; Naser Al Deen N; Caravan W; Houston A; Simin FA; Wyczalkowski MA; Wang LB; Storrs E; Chen S; Illindala R; Li YD; Jayasinghe RG; Rykunov D; Cottingham SL; Chu RK; Weitz KK; Moore RJ; Sagendorf T; Petyuk VA; Nestor M; Bramer LM; Stratton KG; Schepmoes AA; Couvillion SP; Eder J; Kim YM; Gao Y; Fillmore TL; Zhao R; Monroe ME; Southard-Smith AN; Li YE; Jui-Hsien Lu R; Johnson JL; Wiznerowicz M; Hostetter G; Newton CJ; Ketchum KA; Thangudu RR; Barnholtz-Sloan JS; Wang P; Fenyö D; An E; Thiagarajan M; Robles AI; Mani DR; Smith RD; Porta-Pardo E; Cantley LC; Iavarone A; Chen F; Mesri M; Nasrallah MP; Zhang H; Resnick AC; Chheda MG; Rodland KD; Liu T; Ding L; ; Cancer Cell; 2024 Jul; 42(7):1217-1238.e19. PubMed ID: 38981438 [TBL] [Abstract][Full Text] [Related]
2. Proteogenomic and metabolomic characterization of human glioblastoma. Wang LB; Karpova A; Gritsenko MA; Kyle JE; Cao S; Li Y; Rykunov D; Colaprico A; Rothstein JH; Hong R; Stathias V; Cornwell M; Petralia F; Wu Y; Reva B; Krug K; Pugliese P; Kawaler E; Olsen LK; Liang WW; Song X; Dou Y; Wendl MC; Caravan W; Liu W; Cui Zhou D; Ji J; Tsai CF; Petyuk VA; Moon J; Ma W; Chu RK; Weitz KK; Moore RJ; Monroe ME; Zhao R; Yang X; Yoo S; Krek A; Demopoulos A; Zhu H; Wyczalkowski MA; McMichael JF; Henderson BL; Lindgren CM; Boekweg H; Lu S; Baral J; Yao L; Stratton KG; Bramer LM; Zink E; Couvillion SP; Bloodsworth KJ; Satpathy S; Sieh W; Boca SM; Schürer S; Chen F; Wiznerowicz M; Ketchum KA; Boja ES; Kinsinger CR; Robles AI; Hiltke T; Thiagarajan M; Nesvizhskii AI; Zhang B; Mani DR; Ceccarelli M; Chen XS; Cottingham SL; Li QK; Kim AH; Fenyö D; Ruggles KV; Rodriguez H; Mesri M; Payne SH; Resnick AC; Wang P; Smith RD; Iavarone A; Chheda MG; Barnholtz-Sloan JS; Rodland KD; Liu T; Ding L; Cancer Cell; 2021 Apr; 39(4):509-528.e20. PubMed ID: 33577785 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic utility of genetic alterations in distinguishing IDH-wildtype glioblastoma from lower-grade gliomas: Insight from next-generation sequencing analysis of 479 cases. Lee B; Hwang S; Bae H; Choi KH; Suh YL Brain Pathol; 2024 Sep; 34(5):e13234. PubMed ID: 38217295 [TBL] [Abstract][Full Text] [Related]
4. Quantitative Proteomics Reveals Fundamental Regulatory Differences in Oncogenic HRAS and Isocitrate Dehydrogenase (IDH1) Driven Astrocytoma. Doll S; Urisman A; Oses-Prieto JA; Arnott D; Burlingame AL Mol Cell Proteomics; 2017 Jan; 16(1):39-56. PubMed ID: 27834733 [TBL] [Abstract][Full Text] [Related]
5. Intraoperative assessment of isocitrate dehydrogenase mutation status in human gliomas using desorption electrospray ionization-mass spectrometry. Alfaro CM; Pirro V; Keating MF; Hattab EM; Cooks RG; Cohen-Gadol AA J Neurosurg; 2020 Jan; 132(1):180-187. PubMed ID: 30611146 [TBL] [Abstract][Full Text] [Related]
6. Grading of adult diffuse gliomas according to the 2021 WHO Classification of Tumors of the Central Nervous System. Komori T Lab Invest; 2022 Feb; 102(2):126-133. PubMed ID: 34504304 [TBL] [Abstract][Full Text] [Related]
7. Molecular Classification of Gliomas is Associated with Seizure Control: A Retrospective Analysis. Easwaran TP; Lancki N; Henriquez M; Vortmeyer AO; Barbaro NM; Scholtens DM; Ahmed AU; Dey M Neuromolecular Med; 2021 Jun; 23(2):315-326. PubMed ID: 33206320 [TBL] [Abstract][Full Text] [Related]
8. IDH-wildtype glioblastomas and grade III/IV IDH-mutant gliomas show elevated tracer uptake in fibroblast activation protein-specific PET/CT. Röhrich M; Loktev A; Wefers AK; Altmann A; Paech D; Adeberg S; Windisch P; Hielscher T; Flechsig P; Floca R; Leitz D; Schuster JP; Huber PE; Debus J; von Deimling A; Lindner T; Haberkorn U Eur J Nucl Med Mol Imaging; 2019 Nov; 46(12):2569-2580. PubMed ID: 31388723 [TBL] [Abstract][Full Text] [Related]
9. Enrichment of branched chain amino acid transaminase 1 correlates with multiple biological processes and contributes to poor survival of IDH1 wild-type gliomas. Yi L; Fan X; Li J; Yuan F; Zhao J; Nistér M; Yang X Aging (Albany NY); 2021 Jan; 13(3):3645-3660. PubMed ID: 33493139 [TBL] [Abstract][Full Text] [Related]
10. DNA copy number analysis of Grade II-III and Grade IV gliomas reveals differences in molecular ontogeny including chromothripsis associated with IDH mutation status. Cohen A; Sato M; Aldape K; Mason CC; Alfaro-Munoz K; Heathcock L; South ST; Abegglen LM; Schiffman JD; Colman H Acta Neuropathol Commun; 2015 Jun; 3():34. PubMed ID: 26091668 [TBL] [Abstract][Full Text] [Related]
11. Rapid progression to glioblastoma in a subset of IDH-mutated astrocytomas: a genome-wide analysis. Richardson TE; Snuderl M; Serrano J; Karajannis MA; Heguy A; Oliver D; Raisanen JM; Maher EA; Pan E; Barnett S; Cai C; Habib AA; Bachoo RM; Hatanpaa KJ J Neurooncol; 2017 May; 133(1):183-192. PubMed ID: 28421459 [TBL] [Abstract][Full Text] [Related]
12. In vivo Metabolic Profiles as Determined by Wenger KJ; Hattingen E; Franz K; Steinbach J; Bähr O; Pilatus U Clin Neuroradiol; 2019 Mar; 29(1):27-36. PubMed ID: 28983683 [TBL] [Abstract][Full Text] [Related]
15. Differential expression of the TWEAK receptor Fn14 in IDH1 wild-type and mutant gliomas. Hersh DS; Peng S; Dancy JG; Galisteo R; Eschbacher JM; Castellani RJ; Heath JE; Legesse T; Kim AJ; Woodworth GF; Tran NL; Winkles JA J Neurooncol; 2018 Jun; 138(2):241-250. PubMed ID: 29453678 [TBL] [Abstract][Full Text] [Related]
16. Phospholipase Cγ1 (PLCG1) overexpression is associated with tumor growth and poor survival in IDH wild-type lower-grade gliomas in adult patients. Li T; Yang Z; Li H; Zhu J; Wang Y; Tang Q; Shi Z Lab Invest; 2022 Feb; 102(2):143-153. PubMed ID: 34697421 [TBL] [Abstract][Full Text] [Related]
17. Imaging correlates for the 2016 update on WHO classification of grade II/III gliomas: implications for IDH, 1p/19q and ATRX status. Delfanti RL; Piccioni DE; Handwerker J; Bahrami N; Krishnan A; Karunamuni R; Hattangadi-Gluth JA; Seibert TM; Srikant A; Jones KA; Snyder VS; Dale AM; White NS; McDonald CR; Farid N J Neurooncol; 2017 Dec; 135(3):601-609. PubMed ID: 28871469 [TBL] [Abstract][Full Text] [Related]
18. Comparison of Genetic Profiles and Prognosis of High-Grade Gliomas Using Quantitative and Qualitative MRI Features: A Focus on G3 Gliomas. Hong EK; Choi SH; Shin DJ; Jo SW; Yoo RE; Kang KM; Yun TJ; Kim JH; Sohn CH; Park SH; Won JK; Kim TM; Park CK; Kim IH; Lee ST Korean J Radiol; 2021 Feb; 22(2):233-242. PubMed ID: 32932560 [TBL] [Abstract][Full Text] [Related]